Management of Scleritis in Older Adults.
Drugs Aging
; 41(4): 287-302, 2024 Apr.
Article
en En
| MEDLINE
| ID: mdl-38441778
ABSTRACT
Scleritis, an inflammatory disease of the eye affecting scleral tissue, presents unique challenges in the older adult population. Unlike their younger counterparts, older individuals manifest a distinct spectrum of the disease with different underlying etiologies, co-morbidities, altered immune function, and an increased risk of systemic side effects from medication choices. Addressing these complexities necessitates a comprehensive and multidisciplinary approach. Treatment of choice will depend on any underlying cause but generally involves non-steroidal anti-inflammatory drugs, systemic or local corticosteroids, and potentially disease-modifying anti-rheumatic drugs. Utilization of these therapeutic agents in older adults warrants careful consideration because of their potential side-effect profiles. This article critically examines the specific concerns for the use of these drugs in older patients and reviews the existing literature on their use in this specific cohort.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Escleritis
Límite:
Aged
/
Humans
Idioma:
En
Revista:
Drugs & aging
/
Drugs Aging
/
Drugs aging
Asunto de la revista:
GERIATRIA
/
TERAPIA POR MEDICAMENTOS
Año:
2024
Tipo del documento:
Article
País de afiliación:
Nueva Zelanda